Delaying disease progression in COPD with early escalation to triple therapy: a modelling study (DEPICT-2)

Introduction In patients with COPD, dual bronchodilator (long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA)) and triple therapy (inhaled corticosteroid/LAMA/LABA) reduce the risk of exacerbations and lung function decline in the short–mid-term, but their long-term impact is unkno...

Cijeli opis

Bibliografski detalji

Glavni autori:	Dave Singh, Diego Fabian Litewka, Joan B. Soriano, Adrian Rendon, Frederico Leon Arrabal Fernandes, Rafael Páramo-Arroyo, Tim Trinidad, Hakan Günen, Sudeep Acharya, Bhumika Aggarwal, Gur Levy, Chris Compton, Abdelkader El Hasnaoui, Peter Daley-Yates
Format:	Artigo
Jezik:	Inglês
Izdano:	European Respiratory Society 2025-04-01
Serija:	ERJ Open Research
Online pristup:	http://openres.ersjournals.com/content/11/2/00438-2024.full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!